Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0107548003
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Marketed | 02273950 | APOTEX INC | APO-METHYLPHENIDATE | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 5 MG |
Cancelled Post Market | 02326221 | PRO DOC LIMITEE | METHYLPHENIDATE | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 5 MG |
Cancelled Pre Market | 02274280 | NOVOPHARM LIMITED | NOVO-METHYLPHENIDATE | Human | No | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 5.00 MG |
Cancelled Post Market | 02246991 | PHARMEL INC | PHL-METHYLPHENIDATE | Human | No | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 5 MG |
Marketed | 02234749 | PHARMASCIENCE INC | PMS-METHYLPHENIDATE | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 5 MG |
Marketed | 02541637 | KYE PHARMACEUTICALS INC. | QUILLIVANT ER ORAL SUSPENSION | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 5 MG / ML |
Cancelled Post Market | 02247364 | TEVA CANADA LIMITED | RATIO-METHYLPHENIDATE | Human | No | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 5 MG |
Application information
Related information
Contact us
Version 4.0.3